首页 | 本学科首页   官方微博 | 高级检索  
检索        

不同术后镇痛方法对胸外科肿瘤患者免疫功能的影响
引用本文:杨现会,董铁立,李静,吕淼淼.不同术后镇痛方法对胸外科肿瘤患者免疫功能的影响[J].中国医师进修杂志,2009,32(12).
作者姓名:杨现会  董铁立  李静  吕淼淼
作者单位:450014郑州大学第二附属医院麻醉科
摘    要:目的 观察不同术后镇痛方法 对胸外科肿瘤患者免疫功能的影响.方法 选择ASA分级Ⅰ~Ⅱ级,年龄35~65岁行肺癌根治术或食管癌根治术患者40例,随机分为术后自控静脉镇痛(PCIA)组(Ⅰ组,20例)和术后自控硬膜外镇痛(PCEA)组(E组,20例),术后分别行PCLA和PCEA48h.Ⅰ组药物配伍:舒芬太尼1μg/ml和托烷司琼0.05 mg/ml,背景剂量2 ml/h,自控镇痛剂量2 ml,锁定时间15 min;E组在麻醉诱导前于T4-5间隙行硬膜外置管,注射0.33%罗哌卡因6 ml后行PCEA,药物配伍:罗哌卡因2 mg/ml.术后记录视觉模拟评分法(VAS)镇痛评分、Ramsay镇静评分及不良反应情况.分别于麻醉诱导前,术后2h、1 d、3 d、7 d测定患者皮质醇、白细胞介素(IL)-2浓度,自然杀伤细胞(NK细胞)和细胞因子诱导杀伤细胞(CIK细胞)水平.结果 术后2 h I组VAS镇痛评分为(1.8±0.3)分,与E组的(1.8±0.5)分比较差异无统计学意义(P>0.05);术后1、3、7 d E组的Ramsay镇静评分均较Ⅰ组降低(P<0.05);术后2 h、1 d、3 d、7 dE组的皮质醇浓度低于Ⅰ组(P<0.05),IL-2浓度、NK细胞水平、CIK细胞水平均高于Ⅰ组(P<0.05).结论 术后PCEA可增强胸外科肿瘤患者免疫功能,效果优于术后PCIA.

关 键 词:镇痛  硬膜外  肿瘤  疼痛  手术后  免疫  镇痛  静脉

Effect of postoperative analgesia with difference methods on immunity in patients after thoracic tumour surgery
YANG Xian-hui,DONG Tie-li,LI Jing,LV Miao-miao.Effect of postoperative analgesia with difference methods on immunity in patients after thoracic tumour surgery[J].Chinese Journal of Postgraduates of Medicine,2009,32(12).
Authors:YANG Xian-hui  DONG Tie-li  LI Jing  LV Miao-miao
Abstract:Objective To investigate the effect of postoperative analgesia with difference methods on immunity in patients after thoracic tumour surgery. Methods Forty ASA Ⅰ-Ⅱ patients aged 35-65 years old undergoing thoracic tumour surgery were randomized to receive either postoperative patient- controlled intravenous analgesia (PCIA) (group Ⅰ, 20 cases) or patient-controlled epidural analgesia (PCEA) (group E, 20 cases) for 48 h. Medicine compatibility in group Ⅰ: sulfentanyl 1μg/ml, tropisetron 0.05 mg/ml, the PCIA pump was set up to deliver a 5 ml bolus dose with a 15-min lockout interval and background infusion at 2 ml/h. Epidual catheter was placed at T4-5interspace before induction of anesthesia in group E. The PCEA solution contained 2 mg/ml ropivacaine. The PCEA pump was set up to deliver a 2 ml bolus dose with a 15-min lockout interval and background infusion at 2 ml/h after a loading dose of 0.33% ropivacame 6 ml. The VAS score, Ramsay sedation score and complications were reeorded. Blood samples were taken before induction (baseline) and at 2 h and 1st, 3rd and 7th day after surgery for determination of plasma concentrations of cortisol, interleukin 2 (IL-2) and the level of natural killer (NK) cells and eytokine-induced killer (CIK) cells. Results There was no significant difference in VAS score at 2 h after operation between two groups (1.8±0.3) scores in group Ⅰ and (1.8±0.5)scores in group E].Ramsay sedation score at Ist, 3rd and 7th day after operation in group E were significantly lower than those in group Ⅰ (P<0.05), The plasma concentration of cortisol at 2 h and Ist, 3rd, 7th day after operation in group Ewere significantly lower than those in group Ⅰ (P<0.05), the levels of IL-2, NK cells and CIK cells in group E were significantly higher than those in group Ⅰ (P<0.05). Conclusions The efficacy of postoperative PCEA in improving immunity after thoracic tumour surgery is better than that of postoperative PCIA.
Keywords:Analgesia  epidural  Neoplasms  Pain  postoperative  Immunity  Analgesia  intravenous
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号